CLINICAL_TRIALS
trial_result
· 2023-06-02
Clinical Trial Update: Hepatic Hilar Nerve Block Versus Sham in Pain Control During Liver Ablation and TACE Procedures [Phase 4]
Summary
Phase 4 clinical trial updating comparison of hepatic hilar nerve block versus sham for pain control during liver ablation and transarterial chemoembolization (…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Pain Control, Liver Cancer | Phase 4 | Status: UNKNOWN